Portfolio Manager Factsheet

May 2019

The Company underperformed in May due to some idiosyncratic reasons: Alexion Pharmaceuticals sold off after rumours and news of the company’s #1 shareholder was reducing its position in the company. Mylan was down nearly 40% due to news on opioid litigation in the U.S., which caused extreme selling pressure across a host of generic and specialty drug companies. 

Read more »

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.